These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 9703430

  • 1. Exclusion of a p53 germline mutation in a classic Li-Fraumeni syndrome family.
    Evans SC, Mims B, McMasters KM, Foster CJ, deAndrade M, Amos CI, Strong LC, Lozano G.
    Hum Genet; 1998 Jun; 102(6):681-6. PubMed ID: 9703430
    [Abstract] [Full Text] [Related]

  • 2. Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome.
    Frebourg T, Barbier N, Yan YX, Garber JE, Dreyfus M, Fraumeni J, Li FP, Friend SH.
    Am J Hum Genet; 1995 Mar; 56(3):608-15. PubMed ID: 7887414
    [Abstract] [Full Text] [Related]

  • 3. Analysis of Li-Fraumeni syndrome and Li-Fraumeni-like families for germline mutations in Bcl10.
    Stone JG, Eeles RA, Sodha N, Murday V, Sheriden E, Houlston RS.
    Cancer Lett; 1999 Dec 01; 147(1-2):181-5. PubMed ID: 10660104
    [Abstract] [Full Text] [Related]

  • 4. Absence of germline mutations in exons 5-9 of the p53 gene in patients with Li-Fraumeni-like (SBLA) and familial adenomatous polyposis heritable cancer syndromes.
    Moore SK, Zambrano N, Lynch HT, Lipkin M, Kopelovich L.
    Cancer Genet Cytogenet; 1996 Sep 01; 90(2):125-9. PubMed ID: 8830720
    [Abstract] [Full Text] [Related]

  • 5. p53 Testing for Li-Fraumeni and Li-Fraumeni-like syndromes.
    Gonzalez K, Fong C, Buzin C, Sommer SS, Saldivar JS.
    Curr Protoc Hum Genet; 2008 Apr 01; Chapter 10():Unit 10.10. PubMed ID: 18428420
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
    Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Jones PH, Binchy A, Crowther D.
    Cancer Res; 1994 Mar 01; 54(5):1298-304. PubMed ID: 8118819
    [Abstract] [Full Text] [Related]

  • 7. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
    Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ, Evans DG, Birch JM.
    Cancer Res; 1997 Aug 01; 57(15):3245-52. PubMed ID: 9242456
    [Abstract] [Full Text] [Related]

  • 8. [Li-Fraumeni syndrome].
    Frebourg T.
    Bull Cancer; 1997 Jul 01; 84(7):735-40. PubMed ID: 9339200
    [Abstract] [Full Text] [Related]

  • 9. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.
    Plummer SJ, Santibáñez-Koref M, Kurosaki T, Liao S, Noble B, Fain PR, Anton-Culver H, Casey G.
    Oncogene; 1994 Nov 01; 9(11):3273-80. PubMed ID: 7936651
    [Abstract] [Full Text] [Related]

  • 10. Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family.
    Stolzenberg MC, Brugières L, Gardes M, Dessarps-Freichey F, Chompret A, Bressac B, Lenoir G, Bonaïti-Pellié C, Lemerle J, Feunteun J.
    Oncogene; 1994 Oct 01; 9(10):2799-804. PubMed ID: 8084585
    [Abstract] [Full Text] [Related]

  • 11. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
    Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fong CY, Nguyen VQ, Han JH, Lowstuter K, Longmate J, Sommer SS, Weitzel JN.
    J Clin Oncol; 2009 Mar 10; 27(8):1250-6. PubMed ID: 19204208
    [Abstract] [Full Text] [Related]

  • 12. Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining.
    MacGeoch C, Turner G, Bobrow LG, Barnes DM, Bishop DT, Spurr NK.
    J Med Genet; 1995 Mar 10; 32(3):186-90. PubMed ID: 7783166
    [Abstract] [Full Text] [Related]

  • 13. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
    Andrade RC, Dos Santos AC, de Aguirre Neto JC, Nevado J, Lapunzina P, Vargas FR.
    Fam Cancer; 2017 Apr 10; 16(2):243-248. PubMed ID: 27714481
    [Abstract] [Full Text] [Related]

  • 14. Identification of a novel PTEN intronic deletion in Li-Fraumeni syndrome and its effect on RNA processing.
    Brown LT, Sexsmith E, Malkin D.
    Cancer Genet Cytogenet; 2000 Nov 10; 123(1):65-8. PubMed ID: 11120338
    [Abstract] [Full Text] [Related]

  • 15. The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds.
    Siddiqui R, Onel K, Facio F, Nafa K, Diaz LR, Kauff N, Huang H, Robson M, Ellis N, Offit K.
    Fam Cancer; 2005 Nov 10; 4(2):177-81. PubMed ID: 15951970
    [Abstract] [Full Text] [Related]

  • 16. Germline mutations of the p53 tumor-suppressor gene in cancer-prone families: a review.
    Soussi T, Leblanc T, Baruchel A, Schaison G.
    Nouv Rev Fr Hematol (1978); 1993 Feb 10; 35(1):33-6. PubMed ID: 8511038
    [Abstract] [Full Text] [Related]

  • 17. Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53.
    Birch JM, Heighway J, Teare MD, Kelsey AM, Hartley AL, Tricker KJ, Crowther D, Lane DP, Santibáñez-Koref MF.
    Br J Cancer; 1994 Dec 10; 70(6):1176-81. PubMed ID: 7981072
    [Abstract] [Full Text] [Related]

  • 18. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies.
    Pötzsch C, Voigtländer T, Lübbert M.
    J Cancer Res Clin Oncol; 2002 Aug 10; 128(8):456-60. PubMed ID: 12200603
    [Abstract] [Full Text] [Related]

  • 19. Germ line BAX alterations are infrequent in Li-Fraumeni syndrome.
    Barlow JW, Mous M, Wiley JC, Varley JM, Lozano G, Strong LC, Malkin D.
    Cancer Epidemiol Biomarkers Prev; 2004 Aug 10; 13(8):1403-6. PubMed ID: 15298965
    [Abstract] [Full Text] [Related]

  • 20. The first documentation of Li-Fraumeni syndrome in Korea.
    Bang YJ, Kang SH, Kim TY, Jung CW, Oh SM, Choe KJ, Kim NK.
    J Korean Med Sci; 1995 Jun 10; 10(3):205-10. PubMed ID: 8527048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.